You are here:
Chemical Trading — Cross-Sector Exposure
Last Updated:February 25, 2026

About This Investor

JP-B-552

Headquartered in Japan, they are reviewing opportunities for their current mandate. M&A rationale centers on Expanding existing businesses. Geographic preference: ASEAN India. Majority ownership preferred Minority investments are acceptable Revenue: 2 billion or more. They are specifically targeting: Chemical trading company, manufacturing business, and other trading company businesses can also be considered. Indicative ticket size…

Strategic Expansion
$13.1M - $39.3M
Majority preferred | Minority ok | Revenue ≥ USD 13.1M

Request Full Investor Profile

Similar Investors

JP-B-377

Based in Japan, they are currently screening targets across ASEAN.

Business Process Outsourcing (BPO)
Overseas Expansion
$1.96M - $13.1M
Minority / Majority / 100%
JP-B-402

Mandate summary: From Japan, this investor is open to qualified

Pharmaceutical Manufacturing (CDMO)
Indonesia, Vietnam
Strategic Expansion
$6.54M - $13.1M
Majority / 100%
JP-B-640

They are specifically targeting: IT business related. M&A rationale centers

ASEAN, Indonesia, Malaysia, Singapore
Overseas Expansion
$6.54M - $32.7M
Majority / 100% | Revenue ≥ USD 13.1M